Abstract
Diabetes aggravates myocardial ischemia/reperfusion (I/R) injury (MI/RI). The association between high mobility group box 1 protein (HMGB1) and autophagy in diabetic MI/RI remains unknown. Therefore, we investigated whether inhibiting HMGB1 can regulate autophagy in diabetic mice (DM) after I/R injury. I/R models of C57BL/KsJ mice and db/db mice were established. Histological changes, infarct size (IS), HMGB1 protein, and autophagy-related proteins were detected after 24h of reperfusion. In DM treatment groups, anti-HMGB1 antibody (H-Ig) was injected via tail vein after reperfusion for 15min, and the above-mentioned experimental methods were performed at the end of reperfusion. Compared with the I/R group, the pathological myocardial damage and IS were significantly increased in the I/R (DM) group. Additionally, the levels of HMGB1, Beclin1, and LC3II/LC3I ratio were remarkably higher in the I/R (DM) group than those in the I/R group, while p62 level was lower. In the H-Ig (DM) group, injection of H-Ig significantly reduced the IS, as well as alleviated pathological myocardial damage. Moreover, Beclin1, LC3II/LC3I ratio, and p62 levels were notably reversed after this treatment. I/R-induced myocardium was aggravated by diabetes...Continue Reading
References
May 22, 2002·Circulation·Subodh VermaTerrence M Yau
Mar 3, 2007·Circulation Research·Yutaka MatsuiJunichi Sadoshima
Jun 25, 2008·Circulation·Martin AndrassyAngelika Bierhaus
Mar 12, 2010·Reviews in Endocrine & Metabolic Disorders·Doron Aronson, Elazer R Edelman
Sep 8, 2010·The Journal of Cell Biology·Daolin TangMichael T Lotze
Jun 22, 2011·Autophagy·Rui KangDaolin Tang
Jan 17, 2012·The American Journal of Cardiology·Sorin J BrenerGregg W Stone
Oct 16, 2012·Acta Pharmacologica Sinica·Chang-lin ZhaiLi Li
Nov 12, 2013·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Huiling DiaoWanglin Jiang
Jun 5, 2015·Autophagy·Hiromitsu KanamoriShinya Minatoguchi
Jan 1, 2016·Journal of Molecular and Cellular Cardiology·Anne LejayJames W Scholey
Feb 6, 2016·International Journal of Molecular Medicine·Fan OuyangShenghua Zhou
Mar 8, 2017·Mediators of Inflammation·Sheng WangZhongjun Zhang
Jun 2, 2017·Cardiovascular Diabetology·Isabella RussoPasquale Pagliaro
Aug 29, 2017·International Journal of Molecular Sciences·Saori R Yoshii, Noboru Mizushima
Nov 25, 2017·International Journal of Cardiology·Sarah SohJae-Kwang Shim
Dec 6, 2017·Journal of Cellular Physiology·Wei-Qiang HuangFeng Huang
May 2, 2018·Toxicology Letters·Peihua LuoQiaojun He
Jun 30, 2018·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Shiyong WuDongying Zhang
Jul 27, 2018·Journal of Cellular and Molecular Medicine·Si-Yang YuSheng-Hua Zhou
Oct 12, 2018·Cellular and Molecular Life Sciences : CMLS·Angela RaucciMaurizio C Capogrossi
Nov 8, 2018·The Journal of Thoracic and Cardiovascular Surgery·Yikui TianZequan Yang
Feb 21, 2019·Journal of Cellular and Molecular Medicine·Jiyang XueQifeng Zhao
Feb 23, 2019·Journal of Cellular Physiology·Arup Kr MalakarSupriyo Chakraborty
May 31, 2019·Journal of Molecular and Cellular Cardiology·Qiang SuZhen-Bai Qin
Jan 8, 2020·IUBMB Life·Xueyun YanHuaming Cao
Jan 28, 2020·British Journal of Pharmacology·Claudia PennaDerek J Hausenloy
Feb 18, 2020·Journal of Diabetes Investigation·Dengwen ZhangZhengyuan Xia
Oct 13, 2020·International Immunopharmacology·Xinsen ZouMenghua Chen